January 2025: Sickle Cell Treatment Our production of the plant material required for our  sickle cell treatment is being ramped up for a Phase 3 double blind cross-over trial in 2025.  A total of 44 acres of land has been purchased to grow the plants, with a dedicated staff of four full time people providing the husbandry.

October 2024: Ventilator Validation Deep Life Group's UK arm, Open Safety Equipment Ltd, has released its latest respiratory simulator, iBreathe MkIV, providing automated tested of VWAICO2, WOB and other key parameters in real time. This tool provides rapid validation of ventilator performance. For more information: Click here

February 2024: Phase 2 Clinical Trial Success for Anugel(™) A randomised clinical tria completed in on 110 patients, found that Anugel(™) cuts the need for analgesics following surgery, and the product is now progressing to certification. For more information: Click here